View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 15, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

PubMatic to Participate at Upcoming Investor Summit

PubMatic to Participate at Upcoming Investor Summit NO-HEADQUARTERS/REDWOOD CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate at an upcoming investor summit. Details for the event are as follows: Evercore ISI 3rd Annual Nothing But Net Internet Summit in New York on Wednesday May 29, 2024. About PubMatic PubMatic (Nasdaq: PUBM) is an independent technology company maximizing custome...

 PRESS RELEASE

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology In...

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that members of the management team will participate in a virtual fireside chat during the TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO and EHA on May 28, 2024 at 10:30 a.m. ET. Access to a live webcast of this event, a...

Moody’s Ratings rates Markel’s senior notes Baa2

New York , May 13, 2024 - Moody's Ratings (Moody's) has assigned a Baa2 rating to approximately $600 million of senior unsecured notes being issued by Markel Group Inc. (Markel, NYSE: MKL) off its multi-purpose shelf registration. Markel expects to use net proceeds from the offering for general corp...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 11, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

American States Water Company Announces First Quarter 2024 Results

SAN DIMAS, Calif.--(BUSINESS WIRE)-- American States Water Company (NYSE:AWR) today reported basic and fully diluted earnings per share of $0.62 for the quarter ended March 31, 2024, as compared to basic and fully diluted earnings per share of $0.93 for the quarter ended March 31, 2023, a decrease of $0.31 per share that reflects the recording in the first quarter of 2023: (i) the impact of the water general rate case at AWR’s regulated water utility segment, Golden State Water Company (“GSWC”), including retroactive rates related to the full year of 2022 of $0.38, and (ii) approximately a $0....

 PRESS RELEASE

PubMatic Announces Record First Quarter 2024 Financial Results

PubMatic Announces Record First Quarter 2024 Financial Results Revenue and adjusted EBITDA exceeded guidance; Delivered accelerated year-over-year revenue growth of 20%; Net loss of $(2.5) million or (4)% margin; Adjusted EBITDA of $15.1 million or 23% margin, more than double from Q1 2023; Supply Path Optimization represented 50% of total activity; Generated $24.3 million in cash from operating activities and tripled free cash flow over Q1 2023 to $16.3 million NO-HEADQUARTERS/REDWOOD CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent techn...

 PRESS RELEASE

OPKO Health Reports First Quarter 2024 Business Highlights and Financi...

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of BioReference Health. The transaction includes the sale of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health, excludi...

 PRESS RELEASE

Janux Therapeutics Reports First Quarter 2024 Financial Results and Bu...

SAN DIEGO--(BUSINESS WIRE)-- (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today reported financial results for the first quarter ended March 31, 2024 and provided a business update. “We continue to focus on enrollment in the two clinical studies for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008, and we are pleased with the progress,” said David Campbell, Ph.D., President and CEO ...

Ritika Das ... (+3)
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
 PRESS RELEASE

American States Water Company Announces Regular Common Dividends

SAN DIMAS, Calif.--(BUSINESS WIRE)-- On May 6, 2024, the Board of Directors of American States Water Company (NYSE:AWR) approved a quarterly dividend of $0.43 per share on the Common Shares of the company. This action marks the 352nd consecutive dividend payment by the company. For 69 consecutive years, American States Water Company shareholders have received an increase in their calendar year dividend, which places it in an exclusive group of companies on the New York Stock Exchange that have achieved that result. The company’s current policy is to achieve a compound annual growth rate in the...

 PRESS RELEASE

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results ...

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress Azenosertib clinical development plan on track with multiple data readouts in gynecological and other cancer types anticipated in the second half of 2024 and into 2025 Final results from Phase 1 study of azenosertib in combination with gemcitabine in adult and pediatric patients with relapsed or refractory osteosarcoma to be presented at the 2024 ASCO Annual Meeting Projected cash runway into mid-2026 NEW YORK and SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ZNTL), a clinical-stage b...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 4, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2...

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register f...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch